找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Organoid Technology for Disease Modelling and Personalized Treatment; Badrul Hisham Yahaya Book 2022 The Editor(s) (if applicable) and The

[復(fù)制鏈接]
樓主: 使委屈
21#
發(fā)表于 2025-3-25 06:43:51 | 只看該作者
22#
發(fā)表于 2025-3-25 07:52:29 | 只看該作者
Production and Application of Mesenchymal Stem Cell Spheroids for Cartilage and Bone Regeneration,to produce these tissues from stem cells and scaffolds for a long time, combined with some growth factors and inducible factors. However, owing to the complexity of cartilage and bone tissues, these efforts generated limited results. This chapter explores the production and usage of mesenchymal stem
23#
發(fā)表于 2025-3-25 12:59:03 | 只看該作者
24#
發(fā)表于 2025-3-25 18:09:28 | 只看該作者
Genome Editing in Organoid to Improve Understanding of Human Disease,N and TALEN. Although delivering the CRISPR/Cas9 system is still a huge challenge, genome editing is feasible in both cell lines and organoids. The CRISPR/Cas9 system is a useful and effective tool for studying the mechanisms of single-gene or multi-gene diseases and developing genetic models to fin
25#
發(fā)表于 2025-3-25 22:21:13 | 只看該作者
Ethical Implications on Organoid,ience, organoid technology poses complex ethical challenges that may hinder future translational benefits for patients. To encourage ethically acceptable innovation for the benefit of patients, the interdisciplinary conversation between diverse stakeholders in organoid research and its translational
26#
發(fā)表于 2025-3-26 00:10:39 | 只看該作者
27#
發(fā)表于 2025-3-26 06:21:36 | 只看該作者
28#
發(fā)表于 2025-3-26 08:55:59 | 只看該作者
ing, and the American College of Surgeons Committee on Trauma has endorsed this model as a best practice in violence intervention. Guidelines for starting and sustaining these programs are readily available, as is mentorship through the National Network of Hospital-based Violence Intervention Progra
29#
發(fā)表于 2025-3-26 13:34:18 | 只看該作者
30#
發(fā)表于 2025-3-26 18:02:36 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 17:54
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
明溪县| 六安市| 寿阳县| 衡东县| 大关县| 平乡县| 攀枝花市| 休宁县| 枣阳市| 青浦区| 科技| 普洱| 临夏县| 洪泽县| 永清县| 上蔡县| 建湖县| 资中县| 肇州县| 新龙县| 旅游| 佛山市| 墨玉县| 宜良县| 宜丰县| 岑巩县| 阜新市| 孝昌县| 建水县| 陵川县| 石狮市| 荥阳市| 宜州市| 广元市| 读书| 彩票| 宽城| 石泉县| 林芝县| 綦江县| 连州市|